Yea Christopher

CIK 00016911021 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001691102

Recent Transactions

50 trades

Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-24$13.45/sh−4,331→ 223,508 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-22−3,125→ 31,250 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-22+3,125→ 227,839 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-21+3,750→ 224,714 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-21−3,750→ 48,750 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-20$0.00/sh+87,390→ 220,964 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Employee Stock Option (Right to Buy)
2025-11-20−87,390→ 0 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-18$14.48/sh−2,683→ 133,574 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-17−2,431→ 0 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-17−1,774→ 3,548 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-17+4,205→ 136,257 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-25$13.42/sh−1,954→ 132,052 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-08-22−3,125→ 34,375 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-22+3,125→ 134,006 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-22$13.22/sh−2,362→ 130,881 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-08-21−3,750→ 52,500 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-21+3,750→ 133,243 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-18$13.19/sh−2,649→ 129,493 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-17+4,203→ 132,142 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-08-17−2,430→ 2,431 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-08-17−1,773→ 5,322 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-07-09$15.69/sh−30,250→ 127,939 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-07-08+60,000→ 158,189 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-05-23$11.31/sh−1,926→ 98,189 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-05-22−3,125→ 37,500 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-05-22+3,125→ 100,115 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-05-22$11.88/sh−2,317→ 96,990 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-05-21−3,750→ 56,250 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-05-21+3,750→ 99,307 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-05-19$11.84/sh−2,600→ 95,557 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-05-17+4,205→ 98,157 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-05-17−2,431→ 4,861 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-05-17−1,774→ 7,095 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-02-24$10.02/sh−1,918→ 93,952 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-02-22−3,125→ 40,625 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-02-22+3,125→ 95,870 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-02-21+60,000→ 60,000 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-02-18$9.82/sh−2,601→ 92,745 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-02-17−1,774→ 8,869 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-02-17+4,204→ 95,346 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-02-17−2,430→ 7,292 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-11-26$9.87/sh−1,963→ 91,142 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-11-22+3,125→ 93,105 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2024-11-22−3,125→ 43,750 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-11-18$9.26/sh−7,192→ 89,980 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2024-11-17−2,431→ 9,722 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-11-17+11,496→ 97,172 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2024-11-17−1,774→ 10,643 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Performance Stock Units
2024-11-17−7,291→ 0 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-08-23$12.40/sh−1,916→ 85,676 total

Companies

KalVista Pharmaceuticals, Inc.
CHIEF DEVELOPMENT OFFICER
$KALV

Recent Filings

Address

C/O KALVISTA PHARMACEUTICALS, INC 55 CAMBRIDGE PARKWAY, SUITE 901E

CAMBRIDGE, MA, 02142

View on SEC.gov